Heparins

Global Anticoagulants Industry

Retrieved on: 
Tuesday, January 22, 2019
Heparins, Medicine, Clinical medicine, RTT, Blood, Blood tests, Glycosaminoglycans, Anticoagulant, Low molecular weight heparin

Table 58: German 14-Year Perspective for Anticoagulants by Product Type - Percentage Breakdown of Dollar Sales for Oral Anticoagulants and Injectable Anticoagulants (Unfractionated Heparin and Low Molecular Weight Heparin) Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

Key Points: 
  • Table 58: German 14-Year Perspective for Anticoagulants by Product Type - Percentage Breakdown of Dollar Sales for Oral Anticoagulants and Injectable Anticoagulants (Unfractionated Heparin and Low Molecular Weight Heparin) Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    Table 61: Italian 14-Year Perspective for Anticoagulants by Product Type - Percentage Breakdown of Dollar Sales for Oral Anticoagulants and Injectable Anticoagulants (Unfractionated Heparin and Low Molecular Weight Heparin) Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    Table 64: The UK 14-Year Perspective for Anticoagulants by Product Type - Percentage Breakdown of Dollar Sales for Oral Anticoagulants and Injectable Anticoagulants (Unfractionated Heparin and Low Molecular Weight Heparin) Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    Table 67: Spanish 14-Year Perspective for Anticoagulants by Product Type - Percentage Breakdown of Dollar Sales for Oral Anticoagulants and Injectable Anticoagulants (Unfractionated Heparin and Low Molecular Weight Heparin) Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    Table 70: Russian 14-Year Perspective for Anticoagulants by Product Type - Percentage Breakdown of Dollar Sales for Oral Anticoagulants and Injectable Anticoagulants (Unfractionated Heparin and Low Molecular Weight Heparin) Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    Table 71: Rest of Europe Recent Past, Current & Future Analysis for Anticoagulants by Product Type - Oral Anticoagulants and Injectable Anticoagulants (Unfractionated Heparin and Low Molecular Weight Heparin) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    Table 73: Rest of Europe 14-Year Perspective for Anticoagulants by Product Type - Percentage Breakdown of Dollar Sales for Oral Anticoagulants and Injectable Anticoagulants (Unfractionated Heparin and Low Molecular Weight Heparin) Markets for Years 2011, 2017 & 2
    Table 74: Over 65 Years Individuals as % of the Total Population in Select Asian Countries: 2016 (includes corresponding Graph/Chart)
    Table 75: Asia-Pacific Recent Past, Current & Future Analysis for Anticoagulants by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    Table 76: Asia-Pacific Historic Review for Anticoagulants by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2
    Table 77: Asia-Pacific 14-Year Perspective for Anticoagulants by Geographic Region/Country - Percentage Breakdown of Dollar Sales for China, India, and Rest of Asia-Pacific Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    Table 80: Asia-Pacific 14-Year Perspective for Anticoagulants by Product Type - Percentage Breakdown of Dollar Sales for Oral Anticoagulants and Injectable Anticoagulants (Unfractionated Heparin and Low Molecular Weight Heparin) Markets for Years 2011, 2017 & 2

The global anticoagulants market was valued at $24,265 million in 2017, and is expected to reach $43,427 million by 2025, growing at a CAGR of 7.5% from 2018 to 2025

Retrieved on: 
Thursday, December 13, 2018
Medicine, Blood tests, Blood, Heparins, Anticoagulants, Hematology, Medical signs, RTT, Low molecular weight heparin, Vitamin K antagonist, Coagulation, Vitamin K

Anticoagulants, commonly known as blood thinners, are chemical substances that prevent or reduce coagulation of blood and prolong the clotting time.

Key Points: 
  • Anticoagulants, commonly known as blood thinners, are chemical substances that prevent or reduce coagulation of blood and prolong the clotting time.
  • The market has different types of anticoagulant drugs, and each drug works by inhibiting various pathways of blood coagulation.
  • On the basis of drug class, the anticoagulants market is classified as NOACs, heparin & LMWH, vitamin K antagonist, and others.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

Aniara Diagnostica Launches hit-assay.Com Providing Specific Products for Detection of Heparin Induced Thrombocytopenia

Retrieved on: 
Friday, November 23, 2018
Medicine, Immunology, Health, Glycoproteins, Heparins, Immunologic tests, Immune system, Heparin, Antibody, ELISA, Immunoglobulin G, Isotype

Recently the company announced a new site hit-assay.com which highlights the availability of standardized ELISA Methods for the detection of Heparin-dependent antibodies.

Key Points: 
  • Recently the company announced a new site hit-assay.com which highlights the availability of standardized ELISA Methods for the detection of Heparin-dependent antibodies.
  • Enzyme Immuno-assay (HIT) designed for measuring Heparin-dependent antibodies of the IgG isotype, in human plasma.
  • Aniara distributes Hyphen BioMed's entire line of diagnostic and research reagents for Thrombosis, Hemostasis, and Autoimmunity.
  • The Company distributes products in North America, Central America, South America, Sweden, Norway, Denmark, Finland, Lithuania, Latvia, Estonia and Iceland.

Aniara Diagnostica Launches Heparinassay.com Providing Specific Product Information for Quality Control (QC) Measurement of Heparin and Its Analogues

Retrieved on: 
Thursday, October 4, 2018
Coagulation system, Blood, Heparins, Chemistry, Anatomy, Factor X, Thrombin, Chromogenic, Assay, Low molecular weight heparin

USP/EP Compliant Heparin QC Kits Chromogenic Anti-IIa and Anti-Xa methods are used for measuring homogeneous Heparin for Quality Control.

Key Points: 
  • USP/EP Compliant Heparin QC Kits Chromogenic Anti-IIa and Anti-Xa methods are used for measuring homogeneous Heparin for Quality Control.
  • Heparin Anti-IIa (Kinetics) BIOPHEN Heparin Anti-IIa (Kinetics) is a method for measuring Heparin in purified systems.
  • Chromogenic Substrates: Thrombin Chromogenic Substrates for use in the Anti-IIa assay for Quality Control.
  • Chromogenic Substrates: Factor Xa Factor Xa Chromogenic Substrates for use in the Anti-Xa assay for Quality Control.